Abstract
ABSTRACTImmune suppression is recognized as a hallmark of cancer and this notion is largely based on studies on cellular immunity. Our recent studies have demonstrated a potential new mechanism of cancer suppression of immunity by impairment of antibody effector function mediated by proteolytic enzymes in the tumor microenvironment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have